Walleye Trading’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-38,700
Closed -$5.93M 5764
2021
Q1
$5.93M Buy
+38,700
New +$5.26M 0.03% 549
2020
Q3
Sell
-100
Closed -$10K 4855
2020
Q2
$10K Sell
100
-2,100
-95% -$195K ﹤0.01% 4078
2020
Q1
$183K Buy
2,200
+1,300
+144% +$127K ﹤0.01% 2678
2019
Q4
$100K Buy
900
+700
+350% +$72K ﹤0.01% 3552
2019
Q3
$20K Sell
200
-6,000
-97% -$596K ﹤0.01% 3762
2019
Q2
$615K Buy
6,200
+600
+11% +$57.3K 0.01% 2016
2019
Q1
$618K Buy
5,600
+4,400
+367% +$460K ﹤0.01% 2075
2018
Q4
$110K Buy
1,200
+300
+33% +$30.4K ﹤0.01% 3839
2018
Q3
$99K Sell
900
-1,400
-61% -$146K ﹤0.01% 4218
2018
Q2
$215K Buy
+2,300
New +$198K ﹤0.01% 3584

Other funds holding PRAH

Walleye Trading's PRAH Position: Q3 2020 in Review

Walleye Trading sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2020, closing a stake of 436 shares — an estimated $42K sold.

Walleye Trading first reported a position in PRAH in Q4 2015 and held it in 12 quarters. The position peaked at $639K in Q4 2016. 281 funds tracked by Wall St. Rank hold PRAH as of Q3 2020.

  • Walleye Trading reported no remaining PRA Health Sciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • Walleye Trading sold 436 PRA Health Sciences, Inc. shares in Q3 2020, an estimated $42K.
  • Walleye Trading first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 12 quarters.
  • Walleye Trading's PRA Health Sciences, Inc. position peaked at $639K in Q4 2016.
  • 281 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2020.

Based on Walleye Trading's 13F filing for Q3 2020, filed 16 Nov 2020.